Home > PS Ratio > LYKA LABS

LYKA LABS
PS (Price/Sales) Ratio

The Current P/S Ratio of LYKA LABS is 3.13.

Share Price ₹121.3May 30,2025
Market Cap ₹433.0 Cr
Sales-TTM₹138.5 CrTTM-Consolidated Results
Price/Sales3.13xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results
LYKA LABS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of LYKA LABS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of LYKA LABS is calculated as :

Current Market Cap [ ₹433.0 Cr] as on May 30,2025

(/) Sales [ ₹138.5 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 3.13x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for LYKA LABS , the investors are currently willing to pay '3.13 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of LYKA LABS !

The chart below summarizes the trend in P/S Ratio of LYKA LABS over the last five years.

Historical PS (Price/Sales) ratio chart of LYKA LABS


PS Ratio Performance Analysis for LYKA LABS

- LYKA LABS 's latest p/e ratio is 3.13x.

- LYKA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.01x.

- LYKA LABS 's operated at median p/e ratio of 2x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2023 at 3.45x.

- LYKA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.59x.


How does LYKA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
LYKA LABS 138.53.13433.0
SUN PHARMACEUTICAL INDUSTRIES LTD52,578.47.66402,680.0
DIVIS LABORATORIES LTD9,360.018.75175,532.0
CIPLA LTD27,547.64.29118,315.0
TORRENT PHARMACEUTICALS LTD11,516.09.33107,421.0
DR REDDYS LABORATORIES LTD32,643.93.20104,453.0
MANKIND PHARMA LTD12,279.38.31102,080.0
ZYDUS LIFESCIENCES LTD23,241.54.0393,564.7
LUPIN LTD22,707.93.9489,439.2
AUROBINDO PHARMA LTD31,723.72.1066,647.0
ABBOTT INDIA LTD6,409.210.1064,710.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LYKA LABS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.10x
Max industry PS 18.75x
Median industry PS 4.29x
Average industry PS 6.80x



You may also like the below Video Courses